![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/BIOCON.png)
Share the post "Biocon ‘s Q3 2024-25 Latest News: Revenue Decreases by 3.35% Year-on-Year"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company’s sales declined by -3.35 % over the year, substantial increase in net sales/revenue by 6.43 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -90.98 %, Marginal decrease of -9.57% in other income during this quarter. 🔹 Profit over the Year and quarter: Challenges in sustaining profitability for Biocon Limited. Profit dropped by -89.23 % Year to Year, Biocon Limited’s profitability increased by 199.26 % in this quarter. 🔹 EPS over the Year and quarter: EPS declined by -96.20 % Year to Year. EPS decreased by -261.54 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 3953.7 Cr | Rs. 3590.4 Cr | Rs. 3821.4 Cr | + 6.43 % | -3.35 % |
| Expenses | Rs. 3051 Cr | Rs. 2905 Cr | Rs. 3069.6 Cr | + 5.67 % | + 0.61 % |
| Operating Profit | Rs. 902.7 Cr | Rs. 685.4 Cr | Rs. 751.8 Cr | + 9.69 % | -16.72 % |
| OPM % | 22.83 % | 19.09 % | 19.67 % | + 0.58 % | -3.16 % |
| Other Income | Rs. 586.7 Cr | Rs. 58.5 Cr | Rs. 52.9 Cr | -9.57 % | -90.98 % |
| Interest | Rs. 266.7 Cr | Rs. 225.6 Cr | Rs. 223.4 Cr | -0.98 % | -16.24 % |
| Depreciation | Rs. 414.5 Cr | Rs. 419.9 Cr | Rs. 425.4 Cr | + 1.31 % | + 2.63 % |
| Profit before tax | Rs. 808.2 Cr | Rs. 98.4 Cr | Rs. 155.9 Cr | + 58.43 % | -80.71 % |
| Tax % | 6.6 % | 72.46 % | 47.98 % | -24.48 % | + 41.38 % |
| Net Profit | Rs. 753.3 Cr | Rs. 27.1 Cr | Rs. 81.1 Cr | + 199.26 % | -89.23 % |
| EPS in Rs | Rs. 5.51 | Rs. 0.13 | Rs. 0.21 | + 61.54 % | -96.19 % |
Today, we’re looking at Biocon Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a significant year-over-year sales decline of -3.35 %. However, it did see a marginal increase of 6.43 % from the previous quarter. Expenses ticked up slightly by 5.67 % quarter-on-quarter, aligning with the annual rise of 0.61 %. Operating profit, while down -16.72 % compared to last year, faced a quarter-on-quarter increase of 9.69 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -3.16 %, but an expansion of 0.58 % sequentially. Other income fell by -9.57 % compared to the last quarter, despite an annual decline of -90.98 %. Interest expenses dropped significantly by -0.98 % from the previous quarter, yet the year-over-year decrease remains at a moderate -16.24 %. Depreciation costs climbed by 1.31 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 2.63 %. Profit before tax declined annually by -80.71 % but saw an increase from the preceding quarter by 58.43 %.
Tax expenses as a percentage of profits increased slightly by 41.38 % compared to last year, with a more notable quarter-on-quarter decrease of -24.48 %. Net profit fell by -89.23 % year-on-year but experienced a 199.26 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -96.19 % but a quarterly rise of 61.54 %. In summary, Biocon Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 3953.7 Cr | Rs. 3590.4 Cr | Rs. 3821.4 Cr | + 6.43 % | -3.35 % |
| Expenses | Rs. 3051 Cr | Rs. 2905 Cr | Rs. 3069.6 Cr | + 5.67 % | + 0.61 % |
| Operating Profit | Rs. 902.7 Cr | Rs. 685.4 Cr | Rs. 751.8 Cr | + 9.69 % | -16.72 % |
| Net Profit | Rs. 753.3 Cr | Rs. 27.1 Cr | Rs. 81.1 Cr | + 199.26 % | -89.23 % |
| EPS in Rs | Rs. 5.51 | Rs. 0.13 | Rs. 0.21 | + 61.54 % | -96.19 % |
In reviewing Biocon Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -3.35 % year-on-year, however, there was a minor increase of 6.43 % from the previous quarter. Expenses rose by 0.61 % compared to the previous year, with a 5.67 % increase quarter-on-quarter. Operating Profit dropped by -16.72 % annually, and saw a 9.69 % increase from the last quarter.
Net Profit showed yearly decrease of -89.23 %, and experienced a 199.26 % increase from the previous quarter. Earnings Per Share (EPS) fell by -96.19 % annually, however rose by 61.54 % compared to the last quarter. In essence, while Biocon Limited faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/SHYAMTEL.png)
